All News

Docs taking on full risk in value-based care models still years away

March 18, 2019 / ALEX KACIK  The healthcare industry is likely still several years away from assuming full risk in value-based payment models, according to a new survey. A market in which the majority of value-based relationships include both upside and downside shared risk is three to five years off, according to nearly 40% of 185 …

Centinel Spine Appoints Dirk M. Kuyper and Gregory Rainey to its Board of Directors

NEW YORK, March 19, 2019 /PRNewswire/ — Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced the appointment of Dirk M. Kuyper and Gregory Rainey as members of the Company’s Board of Directors. “I am thrilled to welcome both Dirk and Gregory to the Centinel board,” says Centinel Spine Chairman & CEO, John Viscogliosi.  “Both individuals bring …

DJO® Announces Presentation of Independent Clinical Study Using CMF™ Device

March 18, 2019 VISTA, Calif.–(BUSINESS WIRE)–DJO®, a leading global provider of medical technologies designed to get and keep people moving, announced today Oregon Health & Science University’s independent study of patients who have undergone lumbar fusions with use of non-invasive electrical stimulation. The results, presented at Spine Summit 2019 in Miami, Florida, highlight the fusion …

CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics

NESS ZIONA, Israel, March 18, 2019 /PRNewswire/ — CollPlant(NASDAQ: CLGN), a regenerative medicine company, today announced that it has renewed its exclusive distribution agreement with Arthrex for Vergenix™STR for the treatment of tendinopathy. The original distribution agreement, which commenced in December 2016, is now extended through December 31, 2020, with Arthrex serving as the exclusive distributor of CE Marked Vergenix™STR in Europe, the Middle East, India and certain African countries. Vergenix™STR …

Anika Appoints Robert Richard, Ph.D. as Vice President of Research and Development

March 18, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced the appointment of Robert Richard, Ph.D., to the newly created position of Vice President of Research and Development. Dr. Richard is a 20-year research and development …

Untangling The Web Of Hospital Regulation

Mar 15, 2019 / Robert Lord In War and Peace, Leo Tolstoy wrote, “Writing laws is easy, but governing is difficult.” It’s hard to imagine that in 1867, Tolstoy was writing about the regulatory burden on American hospitals, but he might as well have been. When it comes to governing health care, lawmakers and regulators can sometimes …

Centric Medical™ Announces First Clinical Cases with Saturn™ External Fixation System

March 15, 2019 HUNTLEY, Ill.–(BUSINESS WIRE)–Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the first clinical cases of SATURN External Fixation System. This System is comprised of various rings, struts, pins, bolts, and other fixation components intended …

SpineGuard Reports Solid Improvements in Its Full-Year 2018 Financial Results

March 14, 2019 PARIS & SAN FRANCISCO–(BUSINESS WIRE)–Regulatory News: SpineGuard (FR0011464452 – ALSGD)(Paris:ALSGD), an innovative company that deploys its DSG® real time digital technology for surgical guidance intended to secure and streamline skeletal implant placement, reported today its full-year 2018 financial results as approved by the Board of Directors on March 13, 2019. € thousands …

AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft

CENTENNIAL, Colo., March 12, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that ProChondrix® CR now has a two-year shelf life based on the results of real-time testing. ProChondrix CR helps deliver the necessary components for articular cartilage restoration. This next generation of cartilage restoration therapy …

Medicare X could cost hospitals $800 billion over 10 years and disrupt health insurance market, study says

March 13, 2019 / Susan Morse, Senior Editor The proposed Medicare-X Choice Act could cost hospitals $800 billion over 10 years and significantly disrupt the health insurance exchanges, according to a study done on behalf of the American Hospital Association and the Federation of American Hospitals. The Medicare-X Choice Act would build on the Medicare framework to establish …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1